BRAFV600E Expression in Mouse Neuroglial Progenitors Increase Neuronal Excitability, cause appearance of balloon-like cells, Neuronal Mislocalization, and Inflammatory Immune Response

作者: Roman U. Goz , Ari Silas , Sara Buzel , Joseph J. LoTurco

DOI: 10.1101/544973

关键词:

摘要: Abstract BACKGROUND: Frequent de-novo somatic mutations in major components (PI3KCA, AKT3, TSC1, TSC2, mTOR, BRAF) of molecular pathways crucial for cell differentiation, proliferation, growth and migration (mTOR, MAPK) has been previously implicated malformations cortical development (MCDs) low-grade neuroepithelial tumors (LNETs) 1-7 . LNETs are the most frequent found patients undergoing resective surgery refractory epilepsy treatment. BRAFV600E is up to 70% LNETs. Previous studies suggest a causal relationship between those MAPK seizures occurrence, even without presence malformation or tumor 2, 3, 8-13. Recently Koh colleagues 14 showed that mutation may cause through activation RE1-silecing transcription factor (REST). Additionally, they significant downregulation synaptic transmission plasticity decreased expression multiple ion channels subunits including HCN1, KCNQ3, SCN2A SCN3B. The genes GABA receptors protein specific interneurons subpopulations (SST, VIP) suggests dysregulated inhibitory circuits responsible GGs. experimental manipulation - In-Utero electroporation episomal activating Cre plasmids used test their hypothesis mice however activated mutant BRAFV637 only excitatory neurons. And downregulated were confirmed by qRT-PCR whole tissue samples. question how electrophysiological properties affected surrounding neurons changed not addressed. changes conductances neuronal could be inferred from gene profiles. Purpose current work was investigate overactive human mutated incorporated into mouse genome piggyBase transposition increase excitability ex-vivo slices whether it induces histopathological features profile alteration observed (LNETs). METHODS: Using Electroporation we have introduced radial glia progenitors embryonic cortex on background piggyBac transposon system allows incorporation DNA sequence interest genome. Immunohistochemistry examination known markers RNA sequencing Illumina NextSeq 500 examine alterations Whole-cell current- voltage-clamp properties. Unsupervised Hierarchical Clustering Analysis grouping different conditions based Video electrocorticographic recordings transgenic spontaneous seizures. RESULTS: Under GLAST driving promoter induced astrogenesis, caused morphological cells akin balloon-like cells, delayed migration. NESTIN driver increased neurogenesis, some remain close lateral ventricle displaying large soma size compared upper layers. Some immunopositive astroglial marker glial fibrillary acidic (GFAP), both lower layers (Cux1 Ctip2). Gene ontology analysis there tissue-wide inflammatory immune response, complement pathway activation, microglia recruitment astrocytes which supported immunoreactivity microglial iba1, GFAP respectively. In clamp more depolarized resting membrane potential, input resistance, low capacitance, rheobase, action potential (AP) voltage threshold, AP firing frequency. SAG rebound excitation, indicative hyperpolarization depolarizing conductance (IH), voltage-clamp. sustained potassium sensitive tetraethylammonium neurons.. 4 out 59 also post-action waves, frequencies recording when Ca2+ substituted Co2+ extracellular solution (5/24). We show using 20 segregate separately other conditions. Comparison with bearing mechanistic target rapamycin (MTOR) regulatory components, overactivation shown (MCDs), PIK3CAE545K under GLAST+ TSC1 knockdown (KD) CRISPR-Cas9 effects excitability.

参考文章(237)
Albert J Becker, Holger Klein, Thomas Baden, Ludwig Aigner, Sabine Normann, Christian E Elger, Johannes Schramm, Otmar D Wiestler, Ingmar Blümcke, None, Mutational and expression analysis of the reelin pathway components CDK5 and doublecortin in gangliogliomas. Acta Neuropathologica. ,vol. 104, pp. 403- 408 ,(2002) , 10.1007/S00401-002-0570-4
Mitsuko Nakashima, Hirotomo Saitsu, Nobuyuki Takei, Jun Tohyama, Mitsuhiro Kato, Hiroki Kitaura, Masaaki Shiina, Hiroshi Shirozu, Hiroshi Masuda, Keisuke Watanabe, Chihiro Ohba, Yoshinori Tsurusaki, Noriko Miyake, Yingjun Zheng, Tatsuhiro Sato, Hirohide Takebayashi, Kazuhiro Ogata, Shigeki Kameyama, Akiyoshi Kakita, Naomichi Matsumoto, Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb Annals of Neurology. ,vol. 78, pp. 375- 386 ,(2015) , 10.1002/ANA.24444
Karin Boer, Dirk Troost, Wendy Timmermans, Peter C. Van Rijen, Wim G.M. Spliet, Eleonora Aronica, Pi3K-mTOR signaling and AMOG expression in epilepsy-associated glioneuronal tumors. Brain Pathology. ,vol. 20, pp. 234- 244 ,(2010) , 10.1111/J.1750-3639.2009.00268.X
E. C. Beattie, Control of Synaptic Strength by Glial TNFalpha Science. ,vol. 295, pp. 2282- 2285 ,(2002) , 10.1126/SCIENCE.1067859
Ingmar Blümcke, Otmar D Wiestler, None, Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. Journal of Neuropathology and Experimental Neurology. ,vol. 61, pp. 575- 584 ,(2002) , 10.1093/JNEN/61.7.575
Jeffrey C. Magee, Dendritic integration of excitatory synaptic input. Nature Reviews Neuroscience. ,vol. 1, pp. 181- 190 ,(2000) , 10.1038/35044552
John T. Lee, Ling Li, Patricia A. Brafford, Marcia van den Eijnden, Molly B. Halloran, Katrin Sproesser, Nikolas K. Haass, Keiran S.M. Smalley, James Tsai, Gideon Bollag, Meenhard Herlyn, PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas. Pigment Cell & Melanoma Research. ,vol. 23, pp. 820- 827 ,(2010) , 10.1111/J.1755-148X.2010.00763.X
Avanita S. Prabowo, Anand M. Iyer, Tim J. Veersema, Jasper J. Anink, Antoinette Y. N. Schouten-van Meeteren, Wim G. M. Spliet, Pieter C. van Rijen, Cyrille H. Ferrier, David Capper, Maria Thom, Eleonora Aronica, BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors. Brain Pathology. ,vol. 24, pp. 52- 66 ,(2014) , 10.1111/BPA.12081
Eleonora Aronica, Peter B. Crino, Inflammation in epilepsy: Clinical observations Epilepsia. ,vol. 52, pp. 26- 32 ,(2011) , 10.1111/J.1528-1167.2011.03033.X